The largest database of trusted experimental protocols

Au5800 biochemical analyzer

Manufactured by Beckman Coulter
Sourced in United States

The AU5800 biochemical analyzer is a clinical chemistry system designed for high-volume laboratories. It is capable of performing a wide range of clinical chemistry, immunoassay, and special chemistry tests. The AU5800 utilizes various analytical technologies to provide accurate and reliable results.

Automatically generated - may contain errors

16 protocols using au5800 biochemical analyzer

1

Pleural Fluid Biomarker Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A pleural fluid specimen was collected into an anticoagulant‐free tube at the time of patient admission. After centrifugation, the supernatant of the pleural fluid was collected and stored at −70°C until analysis. In both cohorts, homocysteine was measured by a Beckman AU5800 biochemical analyzer in November 2021. The coefficient variations (CVs) of homocysteine were 2.83% and 8.92% at concentrations of 23.35 and 5.53 μmol/L, respectively. The laboratory technician who measured the homocysteine level did not know the patients' clinical details.
Pleural fluid concentrations of glucose, adenosine deaminase (ADA), white blood cells (WBCs), lactate dehydrogenase (LDH), and protein were collected from the medical records of the participants. Pleural glucose was determined by the hexokinase method. LDH was determined by the lactate‐to‐pyruvate method. ADA was determined by the peroxidase method.21 Total protein was determined by the biuret method. LDH, ADA, and glucose were determined by a Beckman AU5800 biochemical analyzer. WBC counts in the pleural fluid were determined by a Sysmex XN 2000 hematology analyzer.
+ Open protocol
+ Expand
2

Metabolic Profile Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
On the day of the study, a senior nursing staff member recorded the subjects’ medical history, including information about any current medications. Following, a physical examination was performed. Waist circumference (WC) was measured horizontally at the natural waist level. BMI was calculated by dividing the subject’s body weight (kg) by the square of their height (m). SBP and diastolic blood pressure (DBP) were measured using standard mercury sphygmomanometers on the right arm of each subject while they were seated.
Blood samples were taken for biochemical analysis after a 10 h fast. Within one hour of collection, plasma was separated from the blood and stored at 30 °C until analysis of the fasting plasma glucose (FPG) and lipid profiles. The FPG level was measured using a glucose oxidase method (YSI 203 glucose analyzer, Yellow Springs Instruments, Yellow Springs, OH, USA). Total cholesterol and triglyceride (TG) levels were measured using a dry, multilayer, analytical slide method with the Fuji Dri-Chem 3000 analyzer (Fuji Photo Film, Tokyo, Japan). Serum high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) concentrations were analyzed using an enzymatic cholesterol assay following dextran sulfate precipitation. The urine microalbumin was determined by turbidimetry using the Beckman Coulter AU 5800 biochemical analyzer.
+ Open protocol
+ Expand
3

Cardiovascular Risk Factors Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPs were measured in the sitting position using a verified electronic sphygmomanometer (OMRON, HEM-907) by a trained physician or nurse, after a 5-mins rest. The average of three consecutive BP readings with one-minute interval in the first visit of each participant was used for the current analysis. Body weight and height were recorded with participants wearing light indoor clothing and no shoes. The health-related behavior and medical history were collected by interview. Current smokers were defined as those who had smoked cigarettes on one or more days in the past 30 days. All the biochemical measurements were performed in the Central Laboratory of Ruijin Hospital (Shanghai, China) using the standard protocols, including serum concentrations of fasting plasma glucose (FPG), serum lipid and creatinine (Scr). Serum homocysteine (Hcy) level was measured by enzymatic cycling method (test kit provided by Axis-Shield Diagnostics Ltd) with Beckman Coulter AU5800 biochemical analyzer (USA, with the repeatability CV as 1.8%).
+ Open protocol
+ Expand
4

Anthropometric and Biochemical Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patient's anthropometric and biochemical measurements were taken at admission. The height and weight were measured to calculate the body mass index (BMI) by using the formula weight/height2 (kg/m2) [24 (link)] while the patients were barefoot and in light clothing. The blood pressure was measured twice after the patient rested about 10 minutes and calculated the average value. The fasting blood samples were taken for measurement of fasting insulin, fasting plasma glucose, lipid profiles, WBC, and monocyte automatically using a Beckman Coulter AU5800 biochemical analyzer (Brea, CA, USA) [24 (link)]. HOMA-IR was calculated by using the formula fasting plasma glucose multiplied by fasting insulin and then divided by 22.5. MHR was determined by dividing the monocyte counts (in 109/l) by HDL-C (in mmol/l). HbA1c was measured by high-performance liquid chromatography on a Tosoh Automated Glycohemoglobin Analyzer HLC-723G11 (Shunan, Yamaguchi, Japan) [24 (link)].
+ Open protocol
+ Expand
5

Biochemical Markers in Clinical Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biochemical markers included total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), Sodium (Na+), potassium (K+), glucose (Glu), uric acid (UA), and creatine kinase (CK), all of them were determined by the AU5800 biochemical analyzer (Beckman Coulter, Brea, CA, United States).
The serum TAFI levels were measured by immune turbidimetry using kits provided by Liaoning Maidi Biological Technology and analyzed by the AU480 automatic biochemical analyzer (Beckman Coulter, Brea, CA, United States).
+ Open protocol
+ Expand
6

Fungal Biomarker Detection Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum and BALF GM were tested with an immunoenzymatic sandwich microplate assay (ELISA) from Bio-Rad laboratories. Optical density index (ODI) of serum GM ≥0.5 was considered as a positive specimen as per instructions.
Kinetic-turbidimetric LAL kit and microbial dynamic monitoring system (ELX 808) were used to test serum BDG. The concentration of serum BDG ≥10 μg/ml was identified as a positive specimen as per instructions. The minimum detection limit is 10 μg/ml for this methodology.
Serum PCT was measured by electrochemiluminescence technique using the Cobas 6000 system (Roche Diagnostic, Germany). Serum CRP was measured by AU5800 Biochemical analyzer (Beckman Coulter, USA). Sputum and BALF cultures were measured using Sabouraud fungal medium and identified by spectrum analyzer (Microflex LT/SH).
+ Open protocol
+ Expand
7

Comparative Analysis of APE and NSTEMI

Check if the same lab product or an alternative is used in the 5 most similar protocols
The clinical manifestations, ECGs, myocardial zymograms, D‐dimers, and cardiac troponin (cTn) in patients with APE and NSTEMI were compared and analyzed. ECG examinations were performed with 12 leads; the paper speed was 25 mm/s and the standard voltage was 10 mv. The specialist in the ECG department had the responsibility of making the final decision on the controversial ECG manifestations. The myocardial zymograms were obtained from blood samples taken from the elbow vein at admission. The instrument used was the Beckman AU5800 biochemical analyzer. D‐dimers and cTn were determined using chemiluminescence. Beckman ACCESS 2 was used as the detection instrument.
+ Open protocol
+ Expand
8

Comprehensive Metabolic Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum levels of fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), TG, total cholesterol (TC), HDL-C, low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), lipoprotein(a) (LP(a)), and small dense low-density lipoprotein (sd-LDL) were measured using the fully automated Beckman AU5800 biochemical analyzer.
+ Open protocol
+ Expand
9

Comprehensive Biomarker Analysis in APL

Check if the same lab product or an alternative is used in the 5 most similar protocols
The obtained information included case mix (age, sex), clinical (initial bleeding events, early hemorrhagic death events, laboratory variables [white blood cell (WBC) counts, hemoglobin (HB) levels, platelet(PLT) counts, prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (Fbg), D-dimer (D-D), lactate dehydrogenase(LDH) and bone marrow leukemic promyelocyte (BMP) percentage]. Routine blood tests were carried out using a Sysmex XT-4000i Hematology Analyzer (Sysmex, Kobe, Japan) on EDTA-anticoagulated blood samples. The Sysmex CS-2000i Automated Hemostasis Analyzer (Sysmex, Kobe, Japan) was used for detecting coagulation parameters such as PT, APTT, fibrinogen level (Clauss method), and D-dimer (Immuno-turbidimetric method). Blood biochemical tests were done on a Beckman Coulter AU5800 biochemical analyzer (Beckman Coulter, USA) on heparin-anticoagulated blood samples. Bone marrow leukemic promyelocytes were microscopically examined by 2 experienced physicians separately. Fusion gene transcript of chromosome aberrations was analyzed by reverse transcription polymerase chain reaction. PML-RARα gene fusion was performed on bone marrow (BM) samples collected at diagnosis of APL.
+ Open protocol
+ Expand
10

Dialysis Patient Blood and Urine Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
During their subsequent visits to our hospital for dialysis, venous blood samples were collected after an 8-hour fasting period for routine hematological and biochemical analyses. The biochemical parameters assessed included serum albumin, calcium, sodium, triglycerides, total cholesterol, hypersensitive C-reactive protein (hs-CRP), and parathyroid hormone, utilizing the Beckman Coulter AU5800 Biochemical Analyzer for measurements. Records of total urine output and dialysate were compiled 24 hours prior to the clinic visit. Concentrations of urea nitrogen and creatinine were determined in the blood, urine, and dialysate samples. Subsequently, the total urea clearance index, total creatinine clearance, and residual renal function were calculated based on these measurements.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!